Treatment-induced blood pressure reduction and the risk of myocardial infarction
- PMID: 2754792
Treatment-induced blood pressure reduction and the risk of myocardial infarction
Abstract
To examine the relationship between degree of treatment-induced blood pressure (BP) reduction and myocardial infarction, the experience of 1765 previously untreated, mild to moderate hypertensives (initial BP greater than or equal to 160 and/or greater than or equal to 95 mm Hg) in a systematic treatment program was reviewed. Over an average of 4.2 years, there were 39 morbid or fatal myocardial infarctions. Three types of fall in diastolic BP (final minus pretreatment) were defined: small (less than or equal to 6 mm Hg), moderate (7 to 17 mm Hg), and large (greater than or equal to 18 mm Hg). By Cox regression, an association was observed between myocardial infarctions and both a large and a small fall, relative to a moderate decline. Age and sex were independent risk factors. Body mass index, cholesterol level, electrocardiogram, race, prior cardiovascular disease, smoking status, initial and final revisit BP, total intreatment BP, and systolic BP were not. Since both a large and small reduction in diastolic BP were associated with a higher incidence of myocardial infarction (relative to a moderate fall), perhaps a moderate reduction in diastolic BP should be the goal of treatment for mild and moderate hypertensives.
Comment in
-
Blood pressure reduction and the risk of myocardial infarction.JAMA. 1990 Feb 2;263(5):660-1. JAMA. 1990. PMID: 2296119 No abstract available.
Similar articles
-
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension.N Engl J Med. 1991 Apr 18;324(16):1098-104. doi: 10.1056/NEJM199104183241605. N Engl J Med. 1991. PMID: 1759997
-
Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction.Hypertension. 1994 Mar;23(3):395-401. doi: 10.1161/01.hyp.23.3.395. Hypertension. 1994. PMID: 8125567
-
Low mortality from all causes, including myocardial infarction, in well-controlled hypertensives treated with a beta-blocker plus other antihypertensives.J Hypertens. 1987 Aug;5(4):489-98. J Hypertens. 1987. PMID: 3668249 Clinical Trial.
-
Efficacy and safety of olmesartan medoxomil in patients with stage 1 hypertension: blood pressure lowering and goal achievement.Postgrad Med. 2010 Nov;122(6):57-67. doi: 10.3810/pgm.2010.11.2224. Postgrad Med. 2010. PMID: 21084783 Review.
-
Future approaches to the treatment of hypertension in the light of results from recent trials.Drugs. 1988;35 Suppl 4:9-15. doi: 10.2165/00003495-198800354-00004. Drugs. 1988. PMID: 3288469 Review.
Cited by
-
The "J curve" problem revisited: old and new findings.Curr Hypertens Rep. 2010 Aug;12(4):290-5. doi: 10.1007/s11906-010-0121-7. Curr Hypertens Rep. 2010. PMID: 20524090 Review.
-
Does a blood pressure J curve exist for patients with chronic kidney disease?J Clin Hypertens (Greenwich). 2017 Aug;19(8):764-770. doi: 10.1111/jch.13024. Epub 2017 Jun 7. J Clin Hypertens (Greenwich). 2017. PMID: 28589557 Free PMC article. Review.
-
Clinical predictors of treatment reduction in hypertensive patients.J Gen Intern Med. 1990 May-Jun;5(3):203-10. doi: 10.1007/BF02600534. J Gen Intern Med. 1990. PMID: 2341919
-
The Hypertension Optimal Treatment Study: what did it give us?Curr Hypertens Rep. 1999 Aug;1(4):337-41. doi: 10.1007/s11906-999-0043-4. Curr Hypertens Rep. 1999. PMID: 10981087
-
Control of Blood Pressure and Cardiovascular Outcomes in Type 2 Diabetes.Open Med (Wars). 2018 Aug 21;13:304-323. doi: 10.1515/med-2018-0048. eCollection 2018. Open Med (Wars). 2018. PMID: 30140748 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical